Log in
RegisterClarity on waiving multiple dose study [Regulatives / Guidelines]
Dear all,
The recently updated MR guideline (EMA/CPMP/EWP/280/96 Corr1) mentions about the possibility of waiving multiple dose study (593-595). However, 612-615 mentions that there isnt sufficient scientific evidence. With the current scenario, would waiving multiple dose study on the basis suggested in 593-595 be a risk? How can a generic company justify scientific evidence for this approach?
593-595
Thank the team in advance for clarification.
The recently updated MR guideline (EMA/CPMP/EWP/280/96 Corr1) mentions about the possibility of waiving multiple dose study (593-595). However, 612-615 mentions that there isnt sufficient scientific evidence. With the current scenario, would waiving multiple dose study on the basis suggested in 593-595 be a risk? How can a generic company justify scientific evidence for this approach?
593-595
A multiple dose study is needed unless a single dose study has been performed with the highest strength which has demonstrated that the mean AUC(0-τ) after the first dose covers more than 90% of mean AUC(0-∞) for both test and reference, and consequently a low extent of accumulation is expected.
612-615The discussion of the opportunity of using equivalence in Cτ in single dose studies as basis for waiving the multiple dose study has been recognized. However, there is not considered to be sufficient scientific evidence at the moment to encourage this approach.
Thank the team in advance for clarification.
Complete thread:
- Draft EMA MR formulations GL published! Ohlbe 2013-03-15 12:10 [Regulatives / Guidelines]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Housekeeping suggestions Helmut 2013-03-15 13:28
- Scaling for pAUCs Helmut 2013-03-15 14:19
- Draft EMA MR formulations GL published! ioanam 2013-03-30 17:54
- Topicals → 1995 NfG Helmut 2013-03-30 22:51
- Topicals, generic ElMaestro 2013-03-31 19:26
- Topicals, generic ioanam 2013-04-01 07:51
- Topicals, generic The Outlaw Torn 2013-04-01 08:03
- Topicals, generic ioanam 2013-04-01 07:51
- Clarity on waiving multiple dose studyTina 2013-05-15 14:19
- Hey, it is just a draft! Helmut 2013-05-17 18:49
- Critical review of García-Arieta et al. (2012) Helmut 2013-06-29 19:44
- Hey, it is just a draft! Helmut 2013-05-17 18:49
- SD vs. MD, partial AUCs Helmut 2013-06-21 19:24
- SD vs. MD, partial AUCs Shuanghe 2013-06-25 17:22
- SD vs. MD, partial AUCs Helmut 2013-06-25 19:15
- SD vs. MD, partial AUCs Shuanghe 2013-06-27 11:07
- pAUCs, alternative metrics, alcohol Helmut 2013-06-27 14:38
- SD vs. MD, partial AUCs Shuanghe 2013-06-27 11:07
- SD vs. MD, partial AUCs Helmut 2013-06-25 19:15
- SD vs. MD, partial AUCs Shuanghe 2013-06-25 17:22
- tmax (DR & multiphasic) Helmut 2013-06-22 01:15
- Presentations of the EUFEPS meeting Helmut 2013-07-15 15:50
- ⧫ Deadline approaching ⧫ Helmut 2013-08-16 16:41
- Download comment form Helmut 2013-08-26 11:28
- Food effect Compliance 2013-08-26 12:04
- Food effect Dr_Dan 2013-08-26 16:48
- Variability (MR vs. IR) Helmut 2013-09-12 15:23
Ing. Helmut Schütz